Egypt begins manufacturing Favipiravir to treat COVID-19
The applications will allow the companies to start taking special administrative and technical procedures toward completing Favipiravir’s registration.
Latest in Tag: Favipiravir Highlight
Latest in Tag: Favipiravir
Sabaa Pharma gets initial approval for COVID-19 drug ‘Favipiravir’ registering
The approval was given by the Ministry of Health’s pharmaceutical regulatory body, the Egyptian Drug Authority (EDA). According to the EDA-issued approval, it is expected that all registration procedures will be completed within three months in preparation for production.